Cargando...
Immune checkpoint blockade and biomarkers of clinical response in non–small cell lung cancer
Immunotherapy with PD‐1 and PD‐L1 inhibitors has revolutionized the treatment for patients with NSCLC the last years with increased overall survival and in particular increased number of long‐time survivors in patients with metastatic disease. It is now a treatment of choice for patients with distan...
Gardado en:
| Publicado en: | Scand J Immunol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7757202/ https://ncbi.nlm.nih.gov/pubmed/33015859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/sji.12980 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|